Cargando…
A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases
OBJECTIVE: The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal i...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019435/ https://www.ncbi.nlm.nih.gov/pubmed/35465075 http://dx.doi.org/10.1155/2022/7360282 |
_version_ | 1784689276710027264 |
---|---|
author | Yeoh, Phillip Dwyer, Andrew A. Anghel, Ella Bouloux, Pierre M. Khoo, Bernard Chew, Shern Wernig, Florian Carroll, Paul Aylwin, Simon J. B. Baldeweg, Stephanie E. Drake, William Todd, Jeannie Mangena, Lindiwe Grossman, Ashley |
author_facet | Yeoh, Phillip Dwyer, Andrew A. Anghel, Ella Bouloux, Pierre M. Khoo, Bernard Chew, Shern Wernig, Florian Carroll, Paul Aylwin, Simon J. B. Baldeweg, Stephanie E. Drake, William Todd, Jeannie Mangena, Lindiwe Grossman, Ashley |
author_sort | Yeoh, Phillip |
collection | PubMed |
description | OBJECTIVE: The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal insulin dose for the ITT. Therefore, we sought to compare the standard dose (0.15 U/kg) and a low-dose ITT (0.1 U/kg). DESIGN: Single-centre audit of ITT data (2012–2021). Patients and Measurements. Patients who underwent an ITT to assess possible GH deficiency/adrenal insufficiency were included. Glucose, GH, and cortisol were measured at baseline and 30, 45, 60, 90, and 120 minutes following I.V. insulin bolus (0.15 U/kg or 0.10 U/kg). RESULTS: Of the ITTs performed, only 3/177 (1.7%) did not achieve adequate hypoglycaemia (≤2.2 mmol/L) with a single insulin dose. In total, 174 patients (43.5 ± 12.1 yrs, mean ± standard deviation) were included for analysis (0.15 U/kg: n = 113, 0.10 U/kg: n = 61). All 174 subjects had adequate hypoglycaemia regardless of baseline fasting blood glucose level or insulin dose. Neither nadir glucose nor glucose delta (i.e., baseline minus nadir) differed between insulin doses. Trends in both cortisol and GH responses over time were similar between groups, and a greater proportion of patients receiving the standard dose had an adequate cortisol response (77/106 (72.6%) vs. 32/60 (53.3%), p=0.01). The rates of glucose rescue did not differ in a subset of 79 patients, with on-demand glucose rescue in 4/35 (11%) for the standard dose and 2/44 (5%) for the low dose (p=0.25). CONCLUSIONS: Our results suggest that the low-dose ITT produces comparable glucose, cortisol, and GH responses to the higher dose. Given the risks associated with hypoglycaemia, the low dose appears to be preferable to the standard dose ITT in most circumstances. |
format | Online Article Text |
id | pubmed-9019435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-90194352022-04-21 A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases Yeoh, Phillip Dwyer, Andrew A. Anghel, Ella Bouloux, Pierre M. Khoo, Bernard Chew, Shern Wernig, Florian Carroll, Paul Aylwin, Simon J. B. Baldeweg, Stephanie E. Drake, William Todd, Jeannie Mangena, Lindiwe Grossman, Ashley Int J Endocrinol Research Article OBJECTIVE: The insulin tolerance test (ITT) is the gold standard endocrine test used to assess the integrity of the growth hormone (GH) and cortisol axes. The ITT has potential risks, and severe hypoglycaemia may necessitate intravenous glucose rescue. There is no clear consensus as to the optimal insulin dose for the ITT. Therefore, we sought to compare the standard dose (0.15 U/kg) and a low-dose ITT (0.1 U/kg). DESIGN: Single-centre audit of ITT data (2012–2021). Patients and Measurements. Patients who underwent an ITT to assess possible GH deficiency/adrenal insufficiency were included. Glucose, GH, and cortisol were measured at baseline and 30, 45, 60, 90, and 120 minutes following I.V. insulin bolus (0.15 U/kg or 0.10 U/kg). RESULTS: Of the ITTs performed, only 3/177 (1.7%) did not achieve adequate hypoglycaemia (≤2.2 mmol/L) with a single insulin dose. In total, 174 patients (43.5 ± 12.1 yrs, mean ± standard deviation) were included for analysis (0.15 U/kg: n = 113, 0.10 U/kg: n = 61). All 174 subjects had adequate hypoglycaemia regardless of baseline fasting blood glucose level or insulin dose. Neither nadir glucose nor glucose delta (i.e., baseline minus nadir) differed between insulin doses. Trends in both cortisol and GH responses over time were similar between groups, and a greater proportion of patients receiving the standard dose had an adequate cortisol response (77/106 (72.6%) vs. 32/60 (53.3%), p=0.01). The rates of glucose rescue did not differ in a subset of 79 patients, with on-demand glucose rescue in 4/35 (11%) for the standard dose and 2/44 (5%) for the low dose (p=0.25). CONCLUSIONS: Our results suggest that the low-dose ITT produces comparable glucose, cortisol, and GH responses to the higher dose. Given the risks associated with hypoglycaemia, the low dose appears to be preferable to the standard dose ITT in most circumstances. Hindawi 2022-02-08 /pmc/articles/PMC9019435/ /pubmed/35465075 http://dx.doi.org/10.1155/2022/7360282 Text en Copyright © 2022 Phillip Yeoh et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yeoh, Phillip Dwyer, Andrew A. Anghel, Ella Bouloux, Pierre M. Khoo, Bernard Chew, Shern Wernig, Florian Carroll, Paul Aylwin, Simon J. B. Baldeweg, Stephanie E. Drake, William Todd, Jeannie Mangena, Lindiwe Grossman, Ashley A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases |
title | A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases |
title_full | A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases |
title_fullStr | A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases |
title_full_unstemmed | A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases |
title_short | A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases |
title_sort | comparison of the blood glucose, growth hormone, and cortisol responses to two doses of insulin (0.15 u/kg vs. 0.10 u/kg) in the insulin tolerance test: a single-centre audit of 174 cases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019435/ https://www.ncbi.nlm.nih.gov/pubmed/35465075 http://dx.doi.org/10.1155/2022/7360282 |
work_keys_str_mv | AT yeohphillip acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT dwyerandrewa acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT anghelella acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT boulouxpierrem acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT khoobernard acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT chewshern acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT wernigflorian acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT carrollpaul acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT aylwinsimonjb acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT baldewegstephaniee acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT drakewilliam acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT toddjeannie acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT mangenalindiwe acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT grossmanashley acomparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT yeohphillip comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT dwyerandrewa comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT anghelella comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT boulouxpierrem comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT khoobernard comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT chewshern comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT wernigflorian comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT carrollpaul comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT aylwinsimonjb comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT baldewegstephaniee comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT drakewilliam comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT toddjeannie comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT mangenalindiwe comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases AT grossmanashley comparisonofthebloodglucosegrowthhormoneandcortisolresponsestotwodosesofinsulin015ukgvs010ukgintheinsulintolerancetestasinglecentreauditof174cases |